15th week of 2019 patent applcation highlights part 7 |
Patent application number | Title | Published |
20190105273 | ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF | 2019-04-11 |
20190105274 | TABLETS CONTAINING ARGININE AT HIGH CONCENTRATION | 2019-04-11 |
20190105275 | ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE | 2019-04-11 |
20190105276 | EXTENDED RELEASE PHARMACEUTICAL FORMULATION | 2019-04-11 |
20190105277 | PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF | 2019-04-11 |
20190105278 | SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS | 2019-04-11 |
20190105279 | MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION | 2019-04-11 |
20190105280 | COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | 2019-04-11 |
20190105281 | COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | 2019-04-11 |
20190105282 | THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF | 2019-04-11 |
20190105283 | DELIVERY SYSTEMS | 2019-04-11 |
20190105284 | Compositions of Xanthorrhizol and Tocochromanol (Tocotrienol), and Methods of Use | 2019-04-11 |
20190105285 | Curcuminoid Chlorophyllin (CHL) Compositions And Methods of Preparation And Use | 2019-04-11 |
20190105286 | Curcuminoid Compositions and Preparation Methods | 2019-04-11 |
20190105287 | Liposomal Curcumin for Treatment of Cancer | 2019-04-11 |
20190105288 | EPINEPHRINE FORMULATIONS | 2019-04-11 |
20190105289 | Compounds for use in the treatment of cancer | 2019-04-11 |
20190105290 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS | 2019-04-11 |
20190105291 | Treatment of cholestatic pruritus | 2019-04-11 |
20190105292 | RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2019-04-11 |
20190105293 | FORMULATION AND METHOD FOR THE PREVENTION AND/OR TREATMENT OF HANGOVER SYMPTOMS | 2019-04-11 |
20190105294 | AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES | 2019-04-11 |
20190105295 | Method Of Treatment Of Obesity | 2019-04-11 |
20190105296 | DIACEREIN OR RHEIN TOPICAL FORMULATIONS AND USES THEREOF | 2019-04-11 |
20190105297 | METHOD OF TREATMENT | 2019-04-11 |
20190105298 | CANNABIS-ENRICHED ENZYMATICALLY TREATED THERAPEUTIC COMPOSITION | 2019-04-11 |
20190105299 | LYMPH DIRECTING PRODRUGS | 2019-04-11 |
20190105300 | ALA AND SALT FORMULATION | 2019-04-11 |
20190105301 | Ready to Use Ketorolac Formulations | 2019-04-11 |
20190105302 | 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS | 2019-04-11 |
20190105303 | PHARMACEUTICAL COMBINATIONS | 2019-04-11 |
20190105304 | TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS | 2019-04-11 |
20190105305 | PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF | 2019-04-11 |
20190105307 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | 2019-04-11 |
20190105308 | METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE | 2019-04-11 |
20190105309 | Formylated N-heterocyclic derivatives as FGFR4 inhibitors. | 2019-04-11 |
20190105310 | PHARMACEUTICAL FORMULATIONS COMPRISING A PYRIDYLAMINOACETIC ACID COMPOUND | 2019-04-11 |
20190105311 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | 2019-04-11 |
20190105312 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | 2019-04-11 |
20190105313 | PSILOCYBIN COMPOSITIONS | 2019-04-11 |
20190105314 | Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-Inhibitors | 2019-04-11 |
20190105315 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | 2019-04-11 |
20190105316 | Inhalable Nicotine Formulations, and Methods of Making and Using Thereof | 2019-04-11 |
20190105317 | Stabilizing Camptothecin Pharmaceutical Compositions | 2019-04-11 |
20190105318 | EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION | 2019-04-11 |
20190105319 | VESICULAR MONOAMINE TRANSPORTER 2 INHIBITORS FOR TREATING STUTTERING | 2019-04-11 |
20190105320 | PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF | 2019-04-11 |
20190105321 | TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY | 2019-04-11 |
20190105322 | Treatment of inflammatory disorders | 2019-04-11 |
20190105323 | TYROSINE KINASE INHIBITORS FOR USE IN A METHOD OF TREATING CANCER IN ASSOCIATION WITH A REDUCED CALORIC INTAKE | 2019-04-11 |
20190105324 | SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES | 2019-04-11 |
20190105325 | LIQUID PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED | 2019-04-11 |
20190105326 | ORAL ENERGY PRODUCTS INCLUDING ENCAPSULATED CAFFEINE | 2019-04-11 |
20190105327 | METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME | 2019-04-11 |
20190105328 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | 2019-04-11 |
20190105329 | ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | 2019-04-11 |
20190105330 | SUSTAINED RELEASE DEXAMETHASONE FORMULATION | 2019-04-11 |
20190105331 | METHODS AND COMPOSITIONS FOR TREATING BROMHIDROSIS, HYPERHIDROSIS, HIDRADENITIS SUPPURATIVA AND RELATED CONDITIONS OF THE HAIR FOLLICLE | 2019-04-11 |
20190105332 | METHODS OF TREATING PROSTATE CANCER | 2019-04-11 |
20190105333 | METHODS FOR INHIBITING MUSCLE ATROPHY | 2019-04-11 |
20190105334 | Anti-Viral Azide Containing Compounds | 2019-04-11 |
20190105335 | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | 2019-04-11 |
20190105336 | PHOSPHOLIPID PREPARATIONS FOR THE IMPROVEMENT OF BRAIN PLASTICITY | 2019-04-11 |
20190105337 | METHODS OF TREATING BACTERIAL INFECTIONS | 2019-04-11 |
20190105338 | GUT HEALTH COMPOSITIONS | 2019-04-11 |
20190105339 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES | 2019-04-11 |
20190105340 | METHODS AND COMPOSITIONS FOR TARGETING VASCULAR MIMICRY | 2019-04-11 |
20190105341 | Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies | 2019-04-11 |
20190105342 | NUCLEIC ACID MOLECULE | 2019-04-11 |
20190105343 | Treatment of Skin Conditions and Diseases Associated with Microbial Biofilms | 2019-04-11 |
20190105344 | ORAL MOLECULAR IODINE COMPOSITION AND METHOD | 2019-04-11 |
20190105345 | Antibacterial Composition and its Use in Treating Bacterial Infections | 2019-04-11 |
20190105346 | METHOD OF PREPARING INJECTION SOLUTION | 2019-04-11 |
20190105347 | USE OF PLA2G5-DEFICIENT SUPPRESSIVE MACROPHAGES IN SUPPRESSION OF INFLAMMATION | 2019-04-11 |
20190105348 | CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY | 2019-04-11 |
20190105349 | SOMATIC STEM CELLS | 2019-04-11 |
20190105350 | Vaccine compositions and methods | 2019-04-11 |
20190105351 | SYSTEMICALLY AND LOCALLY ADMINISTERED CELLS FOR NEUROPATHIC PAIN | 2019-04-11 |
20190105352 | TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS | 2019-04-11 |
20190105353 | SOMATIC STEM CELLS FOR TREATING BONE DEFECTS | 2019-04-11 |
20190105354 | Topical Skin Care Compositions and Methods | 2019-04-11 |
20190105355 | FERTILIZED EGG ISOLATE AND USES THEREOF | 2019-04-11 |
20190105356 | SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION | 2019-04-11 |
20190105357 | Topical Medicament for skin and mucosal injuries | 2019-04-11 |
20190105358 | BIFIDOBACTERIA FOR INCREASING LEAN BODY MASS | 2019-04-11 |
20190105359 | COMPOSITIONS COMPRISING A DEFINED MICROBIOME AND METHODS OF USE THEREOF | 2019-04-11 |
20190105360 | Sequential Anti-Cancer Treatment | 2019-04-11 |
20190105361 | POWDER FORMULATION HAVING A FUNCTION OF ENHANCING IMMUNITY AND METHOD FOR PREPARING THE SAME | 2019-04-11 |
20190105362 | Medicament Containing Taraxacum Plant Root Extract for Treatment or Prevention of Cancer, and Method for Preparing Same | 2019-04-11 |
20190105363 | METHOD OF PRODUCING HIGH-NEPODIN-CONTAINING RUMEX PLANT EXTRACT AND HIGH-NEPODIN-CONTAINING RUMEX PLANT EXTRACT | 2019-04-11 |
20190105364 | METHOD OF USING A GEL, RINSE, AND SPRAY FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH | 2019-04-11 |
20190105365 | COMPOSITION FOR PREVENTING, RELIEVING OR TREATING COLITIS, CONTAINING COMPLEX EXTRACTS | 2019-04-11 |
20190105366 | A METHOD OF TREATING OR PREVENTING SEPSIS | 2019-04-11 |
20190105367 | ANTIMICROBIAL 4-OXOQUINOLIZINES | 2019-04-11 |
20190105368 | Conformationally Specific Viral Immunogens | 2019-04-11 |
20190105369 | CD31SHED AGONISTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF REPERFUSION INJURY | 2019-04-11 |
20190105370 | GLA DOMAINS AS THERAPEUTIC AGENTS | 2019-04-11 |
20190105371 | USES OF CASEIN COMPOSITIONS | 2019-04-11 |
20190105372 | NORRIN REGULATION OF JUNCTION PROTEINS AND THE USE THEREOF TO TREAT EPITHELIAL OR ENDOTHELIAL MEMBRANE LEAKAGE INDUCED EDEMA | 2019-04-11 |
20190105373 | NERVE GROWTH FACTOR MUTANT | 2019-04-11 |